US Patent 8940308 Methods for treating depression
Patent 8940308 was granted and assigned to Allergan, Inc. on January, 2015 by the United States Patent and Trademark Office.
All edits
Edits on 22 Feb, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 3 Dec, 2023
Golden AI
Edits made to:
Article (+234 characters)
Article
Patent abstract
Disclosed is a method for decreasing depression in a patient by local administration of a botulinum neurotoxin to the frontalis, corrugator, procereus, occipitalis, temporalis, trapezius and cervical paraspinal muscles.
Edits on 27 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Catherine C. Turkel0
Mitchell F. Brin0
Edits on 15 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 08940308 Methods for treating depression US Patent 8940308 Methods for treating depression
Infobox
Patent Number
089403080
Patent Number
89403080
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
089403080
Date of Patent
January 27, 2015
0Patent Application Number
137573120
Date Filed
February 1, 2013
0Official Website
Patent Primary Examiner
Edits on 15 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 28 Dec, 2021
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 08940308 Methods for treating depression
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
08940308
Date of patent
January 27, 2015
Patent application number
13757312
Date Filed
February 1, 2013
Patent primary examiner
Find more entities like US Patent 8940308 Methods for treating depression
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.